I read with great pleasure the article entitled ''Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution.'' The results by Akaishi and colleagues and the morbidity/mortality that they report document the feasibility of this new treatment strategy [1] . These authors have established that a dedicated team with a committed leader can perform at a high level of expertise to provide new hope to patients with carcinomatosis. It is clear that these treatment strategies have evolved to the point that they are applicable outside the United States and Europe without compromising the quality of the outcome.
A 4-year overall survival rate of 56% documents the change in our attitude toward this manifestation of cancer. Accepting carcinomatosis as a locoregional extension of cancer allows comprehensive locoregional treatment strategies when employed with great skill to eradicate the disease completely. Not only are there great palliative benefits with prolonged survival, but patients are being cured as a result of this new treatment strategy. The efforts of Akaishi and his colleagues at the Hospital Sirio Libanes in São Paulo, Brazil need to be repeated at hundreds of institutions in South America. This group provides a role model by which other efforts in carcinomatosis should proceed.
The extent of the disease at the current point in time is far greater than our capacity as a health care system to provide treatment. In this respect, this original scientific report takes on great significance for expanding the health care system to patients with carcinomatosis. I congratulate these authors on their important success, which opens a new chapter in oncology.
